Loading…

Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization

Objective To describe the clinical characteristics of pediatric patients with eczema herpeticum and to determine the predictors of hospitalization, and recurrence and repeat episodes. Study design A retrospective cohort study of patients 0-18 years of age diagnosed with eczema herpeticum between May...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 2012-10, Vol.161 (4), p.671-675
Main Authors: Luca, Nadia Jennifer Chiara, MD, Lara-Corrales, Irene, MD, MSc, Pope, Elena, MD, MSc
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603
cites cdi_FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603
container_end_page 675
container_issue 4
container_start_page 671
container_title The Journal of pediatrics
container_volume 161
creator Luca, Nadia Jennifer Chiara, MD
Lara-Corrales, Irene, MD, MSc
Pope, Elena, MD, MSc
description Objective To describe the clinical characteristics of pediatric patients with eczema herpeticum and to determine the predictors of hospitalization, and recurrence and repeat episodes. Study design A retrospective cohort study of patients 0-18 years of age diagnosed with eczema herpeticum between May 2000 and April 2009 was carried out at a tertiary pediatric care center in Canada. Seventy-nine patients were included. The primary outcome was hospitalization; secondary outcomes were recurrent and repeat episodes of eczema herpeticum. Results At presentation, 76% of 79 patients with eczema herpeticum had a generalized eruption, 56% had fever, 37% had systemic symptoms, and 10% had eye involvement (keratoconjunctivitis). Forty-five patients (57%) were hospitalized. Predictors for hospitalization included male sex (OR = 3.09; 95% CI, 1.20-7.95, P = .017), fever (OR = 5.75; 95% CI, 2.17-15.26, P < .001), systemic symptoms (OR = 2.84; 95% CI, 1.06-7.62, P = .035), and age
doi_str_mv 10.1016/j.jpeds.2012.03.057
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1074765714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022347612003666</els_id><sourcerecordid>1074765714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603</originalsourceid><addsrcrecordid>eNqFkk1r1UAUhoMo9rb6CwTNRugm8cxHZhJBQS69XqGgULtxM0wmJzoxyaQzSaH99U56rwpuXM3mec8ZnvckyQsCOQEi3nR5N2ETcgqE5sByKOSjZEOgkpkoGXucbAAozRiX4iQ5DaEDgIoDPE1OKC1kQXm1Sb5dmHscdLpHP-FszTKkdky3P2zfeBzfptvejtboPt2hnhePIdVjk-60mZ0P6RePjTWzvcXUtenehcnOurf3erZufJY8aXUf8PnxPUuudxdft_vs8vPHT9sPl5nhopwzFJw1RENR1lKLghtWt03LBSuBVy00zBheaFJTIaEqWxRGgK5pKWktq0oAO0vOD3Mn724WDLMabDDY93pEtwRFQEYFhSQ8ouyAGu9C8NiqydtB-7sIqVWq6tSDVLVKVcBUlBpTL48LlnrA5k_mt8UIvD4COkRXrdejseEvJyQhZbGuf3XgWu2U_u4jc30VNxWxmVKKh0nvDgRGYbcWvQrG4miiZo9mVo2z__nq-3_y5ljgT7zD0LnFj7ELRVSIGXW1Xsh6IIQCMCEE-wVySLOG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1074765714</pqid></control><display><type>article</type><title>Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization</title><source>Elsevier</source><creator>Luca, Nadia Jennifer Chiara, MD ; Lara-Corrales, Irene, MD, MSc ; Pope, Elena, MD, MSc</creator><creatorcontrib>Luca, Nadia Jennifer Chiara, MD ; Lara-Corrales, Irene, MD, MSc ; Pope, Elena, MD, MSc</creatorcontrib><description>Objective To describe the clinical characteristics of pediatric patients with eczema herpeticum and to determine the predictors of hospitalization, and recurrence and repeat episodes. Study design A retrospective cohort study of patients 0-18 years of age diagnosed with eczema herpeticum between May 2000 and April 2009 was carried out at a tertiary pediatric care center in Canada. Seventy-nine patients were included. The primary outcome was hospitalization; secondary outcomes were recurrent and repeat episodes of eczema herpeticum. Results At presentation, 76% of 79 patients with eczema herpeticum had a generalized eruption, 56% had fever, 37% had systemic symptoms, and 10% had eye involvement (keratoconjunctivitis). Forty-five patients (57%) were hospitalized. Predictors for hospitalization included male sex (OR = 3.09; 95% CI, 1.20-7.95, P = .017), fever (OR = 5.75; 95% CI, 2.17-15.26, P &lt; .001), systemic symptoms (OR = 2.84; 95% CI, 1.06-7.62, P = .035), and age &lt;1 year (OR = 7.17; 95% CI, 2.17-23.72, P = .001). Recurrence rate (&lt;1 month) was 8.9% and rate of repeat episodes (&gt;1 month) was 16%. Hospitalized patients were more likely to have a repeat episode (OR = 8.25; 95% CI, 0.99-68.69, P  = .05). Patients with a previous history of eczema herpeticum had increased likelihood of early recurrence (OR = 6.80; 95% CI, 0.99-46.62, P = .05) and repeat episodes (OR = 9.43; 95% CI, 1.52-55.9, P = .01). Conclusions Predictors of hospitalization in this cohort included male sex, age &lt;1 year, fever, and systemic symptoms at presentation. Hospitalized patients may be at risk for repeat episodes of eczema herpeticum.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2012.03.057</identifier><identifier>PMID: 22575249</identifier><identifier>CODEN: JOPDAB</identifier><language>eng</language><publisher>Maryland Heights, MO: Elsevier Inc</publisher><subject>Acyclovir - therapeutic use ; Adolescent ; Algorithms ; Antiviral Agents - therapeutic use ; Biological and medical sciences ; Bullous diseases of the skin ; Child ; Child, Preschool ; children ; cohort studies ; Dermatology ; eczema ; eyes ; Female ; fever ; General aspects ; Hospitalization - statistics &amp; numerical data ; Human viral diseases ; Humans ; Infant ; Infectious diseases ; Kaposi Varicelliform Eruption - diagnosis ; Kaposi Varicelliform Eruption - drug therapy ; Kaposi Varicelliform Eruption - therapy ; keratoconjunctivitis ; Male ; Medical sciences ; patients ; Pediatrics ; Recurrence ; Retrospective Studies ; risk ; Viral diseases ; Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</subject><ispartof>The Journal of pediatrics, 2012-10, Vol.161 (4), p.671-675</ispartof><rights>Mosby, Inc.</rights><rights>2012 Mosby, Inc.</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603</citedby><cites>FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26711854$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22575249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luca, Nadia Jennifer Chiara, MD</creatorcontrib><creatorcontrib>Lara-Corrales, Irene, MD, MSc</creatorcontrib><creatorcontrib>Pope, Elena, MD, MSc</creatorcontrib><title>Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objective To describe the clinical characteristics of pediatric patients with eczema herpeticum and to determine the predictors of hospitalization, and recurrence and repeat episodes. Study design A retrospective cohort study of patients 0-18 years of age diagnosed with eczema herpeticum between May 2000 and April 2009 was carried out at a tertiary pediatric care center in Canada. Seventy-nine patients were included. The primary outcome was hospitalization; secondary outcomes were recurrent and repeat episodes of eczema herpeticum. Results At presentation, 76% of 79 patients with eczema herpeticum had a generalized eruption, 56% had fever, 37% had systemic symptoms, and 10% had eye involvement (keratoconjunctivitis). Forty-five patients (57%) were hospitalized. Predictors for hospitalization included male sex (OR = 3.09; 95% CI, 1.20-7.95, P = .017), fever (OR = 5.75; 95% CI, 2.17-15.26, P &lt; .001), systemic symptoms (OR = 2.84; 95% CI, 1.06-7.62, P = .035), and age &lt;1 year (OR = 7.17; 95% CI, 2.17-23.72, P = .001). Recurrence rate (&lt;1 month) was 8.9% and rate of repeat episodes (&gt;1 month) was 16%. Hospitalized patients were more likely to have a repeat episode (OR = 8.25; 95% CI, 0.99-68.69, P  = .05). Patients with a previous history of eczema herpeticum had increased likelihood of early recurrence (OR = 6.80; 95% CI, 0.99-46.62, P = .05) and repeat episodes (OR = 9.43; 95% CI, 1.52-55.9, P = .01). Conclusions Predictors of hospitalization in this cohort included male sex, age &lt;1 year, fever, and systemic symptoms at presentation. Hospitalized patients may be at risk for repeat episodes of eczema herpeticum.</description><subject>Acyclovir - therapeutic use</subject><subject>Adolescent</subject><subject>Algorithms</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bullous diseases of the skin</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>children</subject><subject>cohort studies</subject><subject>Dermatology</subject><subject>eczema</subject><subject>eyes</subject><subject>Female</subject><subject>fever</subject><subject>General aspects</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Kaposi Varicelliform Eruption - diagnosis</subject><subject>Kaposi Varicelliform Eruption - drug therapy</subject><subject>Kaposi Varicelliform Eruption - therapy</subject><subject>keratoconjunctivitis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>patients</subject><subject>Pediatrics</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>risk</subject><subject>Viral diseases</subject><subject>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkk1r1UAUhoMo9rb6CwTNRugm8cxHZhJBQS69XqGgULtxM0wmJzoxyaQzSaH99U56rwpuXM3mec8ZnvckyQsCOQEi3nR5N2ETcgqE5sByKOSjZEOgkpkoGXucbAAozRiX4iQ5DaEDgIoDPE1OKC1kQXm1Sb5dmHscdLpHP-FszTKkdky3P2zfeBzfptvejtboPt2hnhePIdVjk-60mZ0P6RePjTWzvcXUtenehcnOurf3erZufJY8aXUf8PnxPUuudxdft_vs8vPHT9sPl5nhopwzFJw1RENR1lKLghtWt03LBSuBVy00zBheaFJTIaEqWxRGgK5pKWktq0oAO0vOD3Mn724WDLMabDDY93pEtwRFQEYFhSQ8ouyAGu9C8NiqydtB-7sIqVWq6tSDVLVKVcBUlBpTL48LlnrA5k_mt8UIvD4COkRXrdejseEvJyQhZbGuf3XgWu2U_u4jc30VNxWxmVKKh0nvDgRGYbcWvQrG4miiZo9mVo2z__nq-3_y5ljgT7zD0LnFj7ELRVSIGXW1Xsh6IIQCMCEE-wVySLOG</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Luca, Nadia Jennifer Chiara, MD</creator><creator>Lara-Corrales, Irene, MD, MSc</creator><creator>Pope, Elena, MD, MSc</creator><general>Elsevier Inc</general><general>Mosby, Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121001</creationdate><title>Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization</title><author>Luca, Nadia Jennifer Chiara, MD ; Lara-Corrales, Irene, MD, MSc ; Pope, Elena, MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acyclovir - therapeutic use</topic><topic>Adolescent</topic><topic>Algorithms</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bullous diseases of the skin</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>children</topic><topic>cohort studies</topic><topic>Dermatology</topic><topic>eczema</topic><topic>eyes</topic><topic>Female</topic><topic>fever</topic><topic>General aspects</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Kaposi Varicelliform Eruption - diagnosis</topic><topic>Kaposi Varicelliform Eruption - drug therapy</topic><topic>Kaposi Varicelliform Eruption - therapy</topic><topic>keratoconjunctivitis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>patients</topic><topic>Pediatrics</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>risk</topic><topic>Viral diseases</topic><topic>Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luca, Nadia Jennifer Chiara, MD</creatorcontrib><creatorcontrib>Lara-Corrales, Irene, MD, MSc</creatorcontrib><creatorcontrib>Pope, Elena, MD, MSc</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luca, Nadia Jennifer Chiara, MD</au><au>Lara-Corrales, Irene, MD, MSc</au><au>Pope, Elena, MD, MSc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>161</volume><issue>4</issue><spage>671</spage><epage>675</epage><pages>671-675</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><coden>JOPDAB</coden><abstract>Objective To describe the clinical characteristics of pediatric patients with eczema herpeticum and to determine the predictors of hospitalization, and recurrence and repeat episodes. Study design A retrospective cohort study of patients 0-18 years of age diagnosed with eczema herpeticum between May 2000 and April 2009 was carried out at a tertiary pediatric care center in Canada. Seventy-nine patients were included. The primary outcome was hospitalization; secondary outcomes were recurrent and repeat episodes of eczema herpeticum. Results At presentation, 76% of 79 patients with eczema herpeticum had a generalized eruption, 56% had fever, 37% had systemic symptoms, and 10% had eye involvement (keratoconjunctivitis). Forty-five patients (57%) were hospitalized. Predictors for hospitalization included male sex (OR = 3.09; 95% CI, 1.20-7.95, P = .017), fever (OR = 5.75; 95% CI, 2.17-15.26, P &lt; .001), systemic symptoms (OR = 2.84; 95% CI, 1.06-7.62, P = .035), and age &lt;1 year (OR = 7.17; 95% CI, 2.17-23.72, P = .001). Recurrence rate (&lt;1 month) was 8.9% and rate of repeat episodes (&gt;1 month) was 16%. Hospitalized patients were more likely to have a repeat episode (OR = 8.25; 95% CI, 0.99-68.69, P  = .05). Patients with a previous history of eczema herpeticum had increased likelihood of early recurrence (OR = 6.80; 95% CI, 0.99-46.62, P = .05) and repeat episodes (OR = 9.43; 95% CI, 1.52-55.9, P = .01). Conclusions Predictors of hospitalization in this cohort included male sex, age &lt;1 year, fever, and systemic symptoms at presentation. Hospitalized patients may be at risk for repeat episodes of eczema herpeticum.</abstract><cop>Maryland Heights, MO</cop><pub>Elsevier Inc</pub><pmid>22575249</pmid><doi>10.1016/j.jpeds.2012.03.057</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2012-10, Vol.161 (4), p.671-675
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_1074765714
source Elsevier
subjects Acyclovir - therapeutic use
Adolescent
Algorithms
Antiviral Agents - therapeutic use
Biological and medical sciences
Bullous diseases of the skin
Child
Child, Preschool
children
cohort studies
Dermatology
eczema
eyes
Female
fever
General aspects
Hospitalization - statistics & numerical data
Human viral diseases
Humans
Infant
Infectious diseases
Kaposi Varicelliform Eruption - diagnosis
Kaposi Varicelliform Eruption - drug therapy
Kaposi Varicelliform Eruption - therapy
keratoconjunctivitis
Male
Medical sciences
patients
Pediatrics
Recurrence
Retrospective Studies
risk
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
title Eczema Herpeticum in Children: Clinical Features and Factors Predictive of Hospitalization
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eczema%20Herpeticum%20in%20Children:%20Clinical%20Features%20and%20Factors%20Predictive%20of%20Hospitalization&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Luca,%20Nadia%20Jennifer%20Chiara,%20MD&rft.date=2012-10-01&rft.volume=161&rft.issue=4&rft.spage=671&rft.epage=675&rft.pages=671-675&rft.issn=0022-3476&rft.eissn=1097-6833&rft.coden=JOPDAB&rft_id=info:doi/10.1016/j.jpeds.2012.03.057&rft_dat=%3Cproquest_cross%3E1074765714%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-e643d1a058b7a654c3bfdf4638049f0d3cc45a1b267098fe6c60ab2872b799603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1074765714&rft_id=info:pmid/22575249&rfr_iscdi=true